Rare Diseases Are Only Rare if You Don't Live With One.®
HAVE YOU OR SOMEONE YOU KNOW BEEN DIAGNOSED WITH NETHERTON SYNDROME?
Netherton syndrome (NS) is a rare hereditary genetic skin disease characterized by scaling skin, hair anomalies, increased susceptibility to atopic eczema, elevated IgE levels, and other related symptoms. Currently, there is no FDA-approved treatment or cure for NS.
Quoin Pharmaceuticals is investigating a potential treatment for NS.
​About Quoin Pharmaceuticals
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises several products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma, Scleroderma, Microcystic Lymphatic Malformations, Venous Malformations, Angiofibroma and others. For more information, visit: www.quoinpharma.com or LinkedIn for updates.
​
​